Elena Verri

1.9k total citations
55 papers, 1.2k citations indexed

About

Elena Verri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Elena Verri has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 26 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Elena Verri's work include Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (10 papers) and HER2/EGFR in Cancer Research (9 papers). Elena Verri is often cited by papers focused on Renal cell carcinoma treatment (10 papers), Cancer Genomics and Diagnostics (10 papers) and HER2/EGFR in Cancer Research (9 papers). Elena Verri collaborates with scholars based in Italy, Spain and United States. Elena Verri's co-authors include Franco Nolè, Gaetano Aurilio, Maria Cossu Rocca, Laura Adamoli, Matteo Santoni, Elisabetta Munzone, Daniela Cullurà, Roberto Iacovelli, Rodolfo Montironi and Alessia Cimadamore and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Elena Verri

53 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena Verri Italy	17	711	551	407	324	156	55	1.2k
Naoki Yanagawa Japan	22	519 0.7×	949 1.7×	285 0.7×	597 1.8×	281 1.8×	109	1.8k
Annette Fisseler‐Eckhoff Germany	22	472 0.7×	631 1.1×	173 0.4×	254 0.8×	324 2.1×	92	1.5k
Rebecca Feldman United States	19	568 0.8×	310 0.6×	270 0.7×	262 0.8×	188 1.2×	68	983
Edgardo S. Santos United States	21	576 0.8×	524 1.0×	230 0.6×	384 1.2×	88 0.6×	101	1.2k
Thomas Makatsoris Greece	22	1.0k 1.4×	338 0.6×	198 0.5×	362 1.1×	147 0.9×	85	1.5k
Silvia Mezi Italy	15	1.0k 1.4×	416 0.8×	201 0.5×	252 0.8×	240 1.5×	51	1.4k
Tyler P. Robin United States	17	608 0.9×	405 0.7×	198 0.5×	330 1.0×	272 1.7×	55	1.3k
A. Ashworth Canada	13	554 0.8×	593 1.1×	278 0.7×	248 0.8×	164 1.1×	26	1.2k
Luciano de Souza Viana Brazil	18	492 0.7×	396 0.7×	223 0.5×	342 1.1×	137 0.9×	37	968
Koung Jin Suh South Korea	18	786 1.1×	475 0.9×	215 0.5×	271 0.8×	178 1.1×	98	1.2k

Countries citing papers authored by Elena Verri

Since Specialization

Citations

This map shows the geographic impact of Elena Verri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Verri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Verri more than expected).

Fields of papers citing papers by Elena Verri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Verri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Verri. The network helps show where Elena Verri may publish in the future.

Co-authorship network of co-authors of Elena Verri

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Verri. A scholar is included among the top collaborators of Elena Verri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Verri. Elena Verri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mistretta, Francesco Alessandro, Stefano Luzzago, Andrea Conti, et al.. (2022). Oligometastatic Prostate Cancer: A Comparison between Multimodality Treatment vs. Androgen Deprivation Therapy Alone. Cancers. 14(9). 2313–2313. 4 indexed citations

Aurilio, Gaetano, Matteo Santoni, Francesco Massari, et al.. (2021). Metabolomic Profiling in Renal Cell Carcinoma Patients: News and Views. Cancers. 13(20). 5229–5229. 13 indexed citations

Marvaso, Giulia, Giulia Corrao, Mattia Zaffaroni, et al.. (2021). Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches. Frontiers in Oncology. 11. 732766–732766. 2 indexed citations

Alterio, Daniela, Lorenzo Preda, Stefania Volpe, et al.. (2020). Impact of a dedicated radiologist as a member of the head and neck tumour board: a single-institution experience. Acta Otorhinolaryngologica Italica. 40(1). 26–32. 8 indexed citations

Alterio, Daniela, Maria Cossu Rocca, William Russell‐Edu, et al.. (2017). Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology. Medical Oncology. 34(5). 86–86. 2 indexed citations

Bossi, Paolo, Diego Cortinovis, Maria Cossu Rocca, et al.. (2016). Searching for Evidence to Support the Use of Ginger in the Prevention of Chemotherapy-Induced Nausea and Vomiting. The Journal of Alternative and Complementary Medicine. 22(6). 486–488. 13 indexed citations

Iacovelli, Roberto, Elena Verri, Maria Cossu Rocca, et al.. (2016). Is there still a role for sorafenib in metastatic renal cell carcinoma? A systematic review and meta-analysis of the effectiveness of sorafenib over other targeted agents. Critical Reviews in Oncology/Hematology. 99. 324–331. 10 indexed citations

Iacovelli, Roberto, Elena Verri, Maria Cossu Rocca, et al.. (2016). Prognostic role of the cumulative toxicity in patients affected by metastatic renal cells carcinoma and treated with first-line tyrosine kinase inhibitors. Anti-Cancer Drugs. 28(2). 206–212. 10 indexed citations

Buti, Sebastiano, Melissa Bersanelli, Francesca Maines, et al.. (2016). First-Line PAzopanib in NOn–clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study. Clinical Genitourinary Cancer. 15(4). e609–e614. 39 indexed citations

10.

Nolè, Franco, Roberto Iacovelli, Elena Verri, et al.. (2015). Prognostic role of PD-L1 expression in renal cell carcinoma. A systematic review and meta-analysis. Annals of Oncology. 26. vi57–vi57. 4 indexed citations

11.

Iacovelli, Roberto, Franco Nolè, Elena Verri, et al.. (2015). Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis. Targeted Oncology. 11(2). 143–148. 147 indexed citations

12.

Rossi, Valentina, Franco Nolè, Stefania Redana, et al.. (2013). Clinical outcome in women with HER2-positive de novo or recurring stage IV breast cancer receiving trastuzumab-based therapy. The Breast. 23(1). 44–49. 21 indexed citations

13.

Jereczek‐Fossa, Barbara Alicja, Alberto d’Onofrio, Gioacchino Giugliano, et al.. (2011). Three-dimensional conformal postoperative radiotherapy in patients with parotid tumors: 10 years' experience at the European Institute of Oncology.. PubMed. 97(3). 328–34. 8 indexed citations

14.

Montemurro, Filippo, Valentina Rossi, Maria Cossu Rocca, et al.. (2011). Hormone‐receptor expression and activity of trastuzumab with chemotherapy in HER2‐positive advanced breast cancer patients. Cancer. 118(1). 17–26. 53 indexed citations

15.

Montemurro, Filippo, Franco Nolè, Stefania Redana, et al.. (2010). Underuse of Anthracyclines in Women with HER-2+ Advanced Breast Cancer. The Oncologist. 15(7). 665–672. 7 indexed citations

16.

Munzone, Elisabetta, Attilio Di Pietro, Aron Goldhirsch, et al.. (2009). Metronomic administration of pegylated liposomal-doxorubicin in extensively pre-treated metastatic breast cancer patients: A mono-institutional case-series report. The Breast. 19(1). 33–37. 23 indexed citations

17.

Botteri, Edoardo, Maria Teresa Sandri, Vincenzo Bagnardi, et al.. (2009). Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Research and Treatment. 122(1). 211–217. 60 indexed citations

18.

Curigliano, Giuseppe, Giosafat Spitaleri, Elisabetta Magni, et al.. (2009). Cisplatin, Etoposide and Continuous Infusion Bleomycin in Patients with Testicular Germ Cell Tumors: Efficacy and Toxicity Data from a Retrospective Study. Journal of Chemotherapy. 21(6). 687–692. 6 indexed citations

19.

Nolè, Franco, Chiara Catania, Elisabetta Munzone, et al.. (2006). Capecitabine/Vinorelbine: An Effective and Well-Tolerated Regimen for Women with Pretreated Advanced-Stage Breast Cancer. Clinical Breast Cancer. 6(6). 518–524. 25 indexed citations

20.

Sanna, Giuseppina, Lorenzo Preda, Roberto Bruschini, et al.. (2006). Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancer. Annals of Oncology. 17(10). 1512–1516. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact